EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA

Recall Number: D-168-2013

Firm: Pacira Pharmaceuticals, Inc.

Classification: Class II

Status: Terminated

Report Date: 20130306

Initiation Date: 20121217

Termination Date: 20130503

Reason for Recall

Subpotent; bupivacaine

Product Description

EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA